Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/6001
DC FieldValueLanguage
dc.contributor.authorZerdan, Maroun Bouen_US
dc.contributor.authorHassan, Sally Alen_US
dc.contributor.authorShaker, Waleeden_US
dc.contributor.authorHajjar, Rayan Elen_US
dc.contributor.authorAllam, Sabineen_US
dc.contributor.authorZerdan, Morgan Bouen_US
dc.contributor.authorNaji, Amalen_US
dc.contributor.authorZeineddine, Nabilen_US
dc.date.accessioned2022-08-16T05:51:36Z-
dc.date.available2022-08-16T05:51:36Z-
dc.date.issued2022-07-
dc.identifier.issn19183003-
dc.identifier.urihttps://scholarhub.balamand.edu.lb/handle/uob/6001-
dc.description.abstractCarbapenem resistance, an emerging global health problem, compromises the treatment of infections caused by nosocomial pathogens. Preclinical and clinical trials demonstrate that a new generation of carbapenemases inhibitors, together with the recently approved avi-bactam, relebactam and vaborbactam, would address this resistance. Our review summarizes the latest developments related to carbap-enemase inhibitors synthesized to date, as well as their spectrum of activity and their current stage of development. A particular focus will be on β-lactam/β-lactamase inhibitor combinations that could potentially be used to treat infections caused by carbapenemase-producer pathogens. These new combinations mark a critical step forward the fight against antimicrobial resistance.en_US
dc.language.isoengen_US
dc.subjectCarbapenem resistanceen_US
dc.subjectCarbapenemase inhibitorsen_US
dc.subjectPathogensen_US
dc.titleCarbapenemase Inhibitors: Updates on Developments in 2021en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.14740/jocmr4764-
dc.identifier.scopus2-s2.0-85135510296-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85135510296-
dc.contributor.affiliationFaculty of Medicineen_US
dc.description.volume14en_US
dc.description.issue7en_US
dc.description.startpage251en_US
dc.description.endpage259en_US
dc.date.catalogued2022-08-16-
dc.description.statusPublisheden_US
dc.identifier.openURLhttps://www.jocmr.org/index.php/JOCMR/article/view/4764/25893586en_US
dc.relation.ispartoftextJournal of Clinical Medicine Researchen_US
dc.description.campusSGH campusen_US
Appears in Collections:Faculty of Medicine
Show simple item record

SCOPUSTM   
Citations

4
checked on Nov 23, 2024

Record view(s)

39
checked on Nov 23, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.